HVII
Hennessy Capital Investment Corp. VII
Financial - Conglomerates
Market Cap$271M
5Y Perf.+6.0%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
HVII vs MS
Revenue, margins, valuation, and 5-year total return — side by side.
MS
Morgan Stanley
Financial - Capital Markets
Market Cap$302.59B
5Y Perf.+42.9%
HVII vs MS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | HVII | MS |
|---|---|---|
| Industry | Financial - Conglomerates | Financial - Capital Markets |
| Market Cap | $271M | $302.59B |
| Revenue (TTM) | $0.00 | $103.14B |
| Net Income (TTM) | $-48K | $16.18B |
| Gross Margin | — | 55.6% |
| Operating Margin | — | 17.1% |
| Forward P/E | — | 16.0x |
| Total Debt | $77K | $360.49B |
| Cash & Equiv. | $20K | $75.74B |
HVII vs MS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
HVII
MS
| Stock | Feb 25 | May 26 | Return |
|---|---|---|---|
| Hennessy Capital In… (HVII) | 100 | 106.0 | +6.0% |
| Morgan Stanley (MS) | 100 | 142.9 | +42.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HVII vs MS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: MS leads in 3 of 4 categories, making it the strongest pick for dividend income and shareholder returns and recent price momentum and sentiment. Hennessy Capital Investment Corp. VII is the stronger pick specifically for capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
HVII
Hennessy Capital Investment Corp. VII
The Banking Pick
HVII is the clearest fit if your priority is income & stability and sleep-well-at-night.
- beta 0.05
- Lower volatility, beta 0.05, current ratio 0.07x
- Beta 0.05, current ratio 0.07x
Best for: income & stability and sleep-well-at-night
MS
Morgan Stanley
The Banking Pick
MS carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 7.3% 10Y total return vs HVII's 6.1%
- 2.0% yield; 11-year raise streak; the other pay no meaningful dividend
- +63.0% vs HVII's +4.4%
Best for: long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Stability / Safety | HVII | Beta 0.05 vs MS's 1.37 |
| Dividends | MS | 2.0% yield; 11-year raise streak; the other pay no meaningful dividend |
| Momentum (1Y) | MS | +63.0% vs HVII's +4.4% |
| Efficiency (ROA) | MS | 1.2% ROA vs HVII's -4.8% |
HVII vs MS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
FY 2024
HVII vs MS — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLMSLAGGINGHVII
HVIIHennessy Capital Inve…
1leads
MSMorgan Stanley
2leads
6 Total Categories
CATEGORYLEADERvs HVIIMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
—
—
Valuation MetricsMultiples, price ratios, and targets
HVII1/1
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
MS3/5
Total Returns1Y, 3Y, 5Y total returns with dividends
MS6/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
Insufficient data to determine a leader in this category.
Income & Cash Flow (Last 12 Months)
MS and HVII operate at a comparable scale, with $103.1B and $0 in trailing revenue.
| Metric | HVIIHennessy Capital … | MSMorgan Stanley |
|---|---|---|
| RevenueTrailing 12 months | $0 | $103.1B |
| EBITDAEarnings before interest/tax | — | $26.3B |
| Net IncomeAfter-tax profit | — | $16.2B |
| Free Cash FlowCash after capex | — | -$6.7B |
| Gross MarginGross profit ÷ Revenue | — | +55.6% |
| Operating MarginEBIT ÷ Revenue | — | +17.1% |
| Net MarginNet income ÷ Revenue | — | +13.0% |
| FCF MarginFCF ÷ Revenue | — | -2.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | — | +48.9% |
Insufficient data to determine a leader in this category.
Valuation Metrics
HVII leads this category, winning 1 of 1 comparable metric.
Valuation Metrics
| Metric | HVIIHennessy Capital … | MSMorgan Stanley |
|---|---|---|
| Market CapShares × price | $271M | $302.6B |
| Enterprise ValueMkt cap + debt − cash | $271M | $587.3B |
| Trailing P/EPrice ÷ TTM EPS | -5788.89x | 23.92x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 16.01x |
| PEG RatioP/E ÷ EPS growth rate | — | 2.69x |
| EV / EBITDAEnterprise value multiple | — | 25.81x |
| Price / SalesMarket cap ÷ Revenue | — | 2.93x |
| Price / BookPrice ÷ Book value/share | — | 2.91x |
| Price / FCFMarket cap ÷ FCF | — | — |
HVII leads this category, winning 1 of 1 comparable metric.
Profitability & Efficiency
MS leads this category, winning 3 of 5 comparable metrics.
Profitability & Efficiency
On the Piotroski fundamental quality scale (0–9), MS scores 5/9 vs HVII's 4/9, reflecting solid financial health.
| Metric | HVIIHennessy Capital … | MSMorgan Stanley |
|---|---|---|
| ROE (TTM)Return on equity | — | +14.6% |
| ROA (TTM)Return on assets | -4.8% | +1.2% |
| ROICReturn on invested capital | — | +2.9% |
| ROCEReturn on capital employed | -11.2% | +3.8% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 5 |
| Debt / EquityFinancial leverage | — | 3.42x |
| Net DebtTotal debt minus cash | $56,785 | $284.7B |
| Cash & Equiv.Liquid assets | $20,005 | $75.7B |
| Total DebtShort + long-term debt | $76,790 | $360.5B |
| Interest CoverageEBIT ÷ Interest expense | — | 0.44x |
MS leads this category, winning 3 of 5 comparable metrics.
Total Returns (Dividends Reinvested)
MS leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MS five years ago would be worth $23,624 today (with dividends reinvested), compared to $10,611 for HVII. Over the past 12 months, MS leads with a +63.0% total return vs HVII's +4.4%. The 3-year compound annual growth rate (CAGR) favors MS at 33.6% vs HVII's 2.0% — a key indicator of consistent wealth creation.
| Metric | HVIIHennessy Capital … | MSMorgan Stanley |
|---|---|---|
| YTD ReturnYear-to-date | +0.4% | +5.7% |
| 1-Year ReturnPast 12 months | +4.4% | +63.0% |
| 3-Year ReturnCumulative with dividends | +6.1% | +138.4% |
| 5-Year ReturnCumulative with dividends | +6.1% | +136.2% |
| 10-Year ReturnCumulative with dividends | +6.1% | +732.3% |
| CAGR (3Y)Annualised 3-year return | +2.0% | +33.6% |
MS leads this category, winning 6 of 6 comparable metrics.
Risk & Volatility
Evenly matched — HVII and MS each lead in 1 of 2 comparable metrics.
Risk & Volatility
HVII is the less volatile stock with a 0.05 beta — it tends to amplify market swings less than MS's 1.37 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | HVIIHennessy Capital … | MSMorgan Stanley |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.05x | 1.37x |
| 52-Week HighHighest price in past year | $10.99 | $194.83 |
| 52-Week LowLowest price in past year | $9.98 | $118.20 |
| % of 52W HighCurrent price vs 52-week peak | +94.8% | +97.6% |
| RSI (14)Momentum oscillator 0–100 | 63.0 | 66.0 |
| Avg Volume (50D)Average daily shares traded | 36K | 5.4M |
Evenly matched — HVII and MS each lead in 1 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
MS is the only dividend payer here at 2.00% yield — a key consideration for income-focused portfolios.
| Metric | HVIIHennessy Capital … | MSMorgan Stanley |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $205.75 |
| # AnalystsCovering analysts | — | 52 |
| Dividend YieldAnnual dividend ÷ price | — | +2.0% |
| Dividend StreakConsecutive years of raises | — | 11 |
| Dividend / ShareAnnual DPS | — | $3.81 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.4% |
Insufficient data to determine a leader in this category.
Key Takeaway
MS leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). HVII leads in 1 (Valuation Metrics). 1 tied.
Best OverallMorgan Stanley (MS)Leads 2 of 6 categories
Loading custom metrics...
HVII vs MS: Frequently Asked Questions
7 questions · data-driven answers · updated daily
01Is HVII or MS a better buy right now?
Morgan Stanley (MS) offers the better valuation at 23.
9x trailing P/E (16. 0x forward), making it the more compelling value choice. Analysts rate Morgan Stanley (MS) a "Buy" — based on 52 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — HVII or MS?
Over the past 5 years, Morgan Stanley (MS) delivered a total return of +136.
2%, compared to +6. 1% for Hennessy Capital Investment Corp. VII (HVII). Over 10 years, the gap is even starker: MS returned +732. 3% versus HVII's +6. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — HVII or MS?
By beta (market sensitivity over 5 years), Hennessy Capital Investment Corp.
VII (HVII) is the lower-risk stock at 0. 05β versus Morgan Stanley's 1. 37β — meaning MS is approximately 2673% more volatile than HVII relative to the S&P 500.
04Which has better profit margins — HVII or MS?
Morgan Stanley (MS) is the more profitable company, earning 13.
0% net margin versus 0. 0% for Hennessy Capital Investment Corp. VII — meaning it keeps 13. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MS leads at 17. 1% versus 0. 0% for HVII. At the gross margin level — before operating expenses — MS leads at 55. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
05Which pays a better dividend — HVII or MS?
In this comparison, MS (2.
0% yield) pays a dividend. HVII does not pay a meaningful dividend and should not be held primarily for income.
06Is HVII or MS better for a retirement portfolio?
For long-horizon retirement investors, Hennessy Capital Investment Corp.
VII (HVII) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 05)). Both have compounded well over 10 years (HVII: +6. 1%, MS: +732. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
07What are the main differences between HVII and MS?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: HVII is a small-cap quality compounder stock; MS is a large-cap high-growth stock. MS pays a dividend while HVII does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.